Industry News | tctmd.com

News Industry News

Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent

January 25, 2011

News Industry News

Merck Statement on Changes to Clinical Studies of Vorapaxar

January 12, 2011

News Industry News

Plans For Largest Ever Drug-Eluting Stent Randomized Clinical Trial Announced at EuroPCR

May 18, 2011

News Industry News

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

May 12, 2011

News Industry News

Medtronic Announces FDA Clearance and First Patient Procedure with the Achieve™ Mapping Catheter

May 02, 2011

News Industry News

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

April 04, 2011

News Industry News

New Data Confirms Safety of BioMatrix™ at One Year

May 19, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

April 04, 2011

News Industry News

Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan

January 18, 2011

Subscribe to Industry News

Advertisement

Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent

Merck Statement on Changes to Clinical Studies of Vorapaxar

Plans For Largest Ever Drug-Eluting Stent Randomized Clinical Trial Announced at EuroPCR

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

Medtronic Announces FDA Clearance and First Patient Procedure with the Achieve™ Mapping Catheter

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

New Data Confirms Safety of BioMatrix™ at One Year

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content